Free Trial

Avita Medical (RCEL) Competitors

Avita Medical logo
$4.02 +0.06 (+1.52%)
Closing price 10/23/2025 04:00 PM Eastern
Extended Trading
$4.01 -0.01 (-0.22%)
As of 10/23/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RCEL vs. DCTH, TMCI, CARL, SMLR, NPCE, RXST, TCMD, DRTS, BWAY, and SNWV

Should you be buying Avita Medical stock or one of its competitors? The main competitors of Avita Medical include Delcath Systems (DCTH), Treace Medical Concepts (TMCI), Carlsmed (CARL), Semler Scientific (SMLR), NeuroPace (NPCE), RxSight (RXST), Tactile Systems Technology (TCMD), Alpha Tau Medical (DRTS), Brainsway (BWAY), and Sanuwave Health (SNWV). These companies are all part of the "medical equipment" industry.

Avita Medical vs. Its Competitors

Avita Medical (NASDAQ:RCEL) and Delcath Systems (NASDAQ:DCTH) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk, media sentiment and analyst recommendations.

Delcath Systems has a net margin of 3.18% compared to Avita Medical's net margin of -68.87%. Delcath Systems' return on equity of 6.91% beat Avita Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Avita Medical-68.87% -632.62% -71.52%
Delcath Systems 3.18%6.91%5.80%

In the previous week, Delcath Systems had 14 more articles in the media than Avita Medical. MarketBeat recorded 28 mentions for Delcath Systems and 14 mentions for Avita Medical. Delcath Systems' average media sentiment score of 0.11 beat Avita Medical's score of 0.07 indicating that Delcath Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Avita Medical
2 Very Positive mention(s)
1 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Delcath Systems
2 Very Positive mention(s)
3 Positive mention(s)
7 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Neutral

Avita Medical presently has a consensus price target of $10.80, suggesting a potential upside of 168.66%. Delcath Systems has a consensus price target of $24.00, suggesting a potential upside of 131.21%. Given Avita Medical's higher possible upside, analysts plainly believe Avita Medical is more favorable than Delcath Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avita Medical
3 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.86
Delcath Systems
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80

Avita Medical has a beta of 1.64, indicating that its share price is 64% more volatile than the S&P 500. Comparatively, Delcath Systems has a beta of 0.84, indicating that its share price is 16% less volatile than the S&P 500.

Delcath Systems has lower revenue, but higher earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avita Medical$64.25M1.67-$61.85M-$1.97-2.04
Delcath Systems$37.21M9.76-$26.39M$0.05207.60

27.7% of Avita Medical shares are owned by institutional investors. Comparatively, 61.1% of Delcath Systems shares are owned by institutional investors. 2.8% of Avita Medical shares are owned by company insiders. Comparatively, 17.4% of Delcath Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Delcath Systems beats Avita Medical on 13 of the 16 factors compared between the two stocks.

Get Avita Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for RCEL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RCEL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RCEL vs. The Competition

MetricAvita MedicalMED IndustryMedical SectorNASDAQ Exchange
Market Cap$105.41M$2.64B$6.18B$10.59B
Dividend YieldN/A57.75%5.72%4.86%
P/E Ratio-2.0423.9429.6728.46
Price / Sales1.67778.82579.41225.02
Price / CashN/A165.1936.5560.64
Price / Book23.655.5712.076.53
Net Income-$61.85M$33.06M$3.32B$276.75M
7 Day Performance0.75%2.10%0.64%0.93%
1 Month Performance-23.43%5.91%5.17%1.41%
1 Year Performance-60.32%-2.82%61.77%31.59%

Avita Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RCEL
Avita Medical
2.68 of 5 stars
$4.02
+1.5%
$10.80
+168.7%
-61.3%$105.41M$64.25M-2.04130Analyst Downgrade
DCTH
Delcath Systems
2.7474 of 5 stars
$11.42
-4.6%
$25.33
+121.8%
-7.2%$418.73M$37.21M228.4060Trending News
Analyst Forecast
Analyst Revision
High Trading Volume
TMCI
Treace Medical Concepts
2.4245 of 5 stars
$6.80
+5.6%
$9.67
+42.2%
+33.7%$406.83M$209.36M-8.61250
CARL
Carlsmed
N/A$14.39
+6.2%
N/AN/A$360.17M$38.27M0.00100News Coverage
Positive News
Short Interest ↑
SMLR
Semler Scientific
3.5371 of 5 stars
$23.65
+2.0%
$74.25
+214.0%
-14.0%$351M$56.29M9.73120
NPCE
NeuroPace
2.3765 of 5 stars
$10.74
+3.2%
$16.60
+54.6%
+78.8%$344.38M$79.91M-12.79170
RXST
RxSight
2.1912 of 5 stars
$8.53
+3.5%
$10.00
+17.2%
-82.6%$337.15M$147.06M-10.66220
TCMD
Tactile Systems Technology
3.679 of 5 stars
$14.61
+0.6%
$16.83
+15.2%
+4.7%$323.90M$292.98M23.561,037Positive News
DRTS
Alpha Tau Medical
2.6534 of 5 stars
$4.00
+6.7%
$9.00
+125.0%
+87.1%$318.08MN/A-8.3380Analyst Forecast
Gap Down
BWAY
Brainsway
3.295 of 5 stars
$15.88
-0.8%
$18.00
+13.4%
+74.1%$304.06M$41.02M61.08120Positive News
SNWV
Sanuwave Health
2.1926 of 5 stars
$31.30
-7.8%
$54.00
+72.5%
N/A$290.71M$39.19M-3.7940Short Interest ↑

Related Companies and Tools


This page (NASDAQ:RCEL) was last updated on 10/24/2025 by MarketBeat.com Staff
From Our Partners